PPIF and diabetes mellitus: In this work, we have tried to answer the question of whether the novel inhibitor cyclophilin D and the MPT pore opening alisporivir, a non-immunosuppressive analogue of cyclosporin A, is capable of suppressing the development of mitochondrial dysfunction in skeletal muscle in diabetes mellitus.